Experimental shot aims to stabilize dangerous blood sugar drops after bariatric surgery
NCT ID NCT07029412
Summary
This study is testing whether a single injection called MBX 1416 can help prevent dangerously low blood sugar in people who have had weight-loss surgery. About 10 participants will receive the injection and have their blood sugar measured after eating test meals to see if their levels stay safer. The goal is to see if this treatment can better control this common and disruptive side effect of bariatric surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTBARIATRIC HYPOGLYCEMIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
MBX Biosciences Investigational Site
RECRUITINGAurora, Colorado, 80045, United States
-
MBX Biosciences Investigational Site
RECRUITINGMorehead City, North Carolina, 28557, United States
-
MBX Biosciences Investigational Site
RECRUITINGKnoxville, Tennessee, 37920, United States
-
MBX Biosciences Investigational Site
RECRUITINGSan Antonio, Texas, 78229, United States
Conditions
Explore the condition pages connected to this study.